"Nobody said that beta-caryophyllene gets you high. It is a full CB2 agonist that has been shown to displace other cannabinoids. It's also been proven that CB1 and CB2 form functional heteromers and negatively modulate one another. Therefor it's not much of a leap of faith to assume that beta-caryophyllene present in high enough amounts modulates THC in at least those two ways. That's just one example. "
I have not tested if beta-caryophyllene effects the high from Cannabis in a negative way, with a test of 100% pure THC (25mg) spiked with beta-caryophyllene and vaporized I did not notice it. I was really looking for any positive effects on the THC effects, there were none.
I do not like the smell or taste of beta-caryophyllene, it smells like hemp to me. I have smelled a lot of hemp in my life....
-SamS
I have not tested if beta-caryophyllene effects the high from Cannabis in a negative way, with a test of 100% pure THC (25mg) spiked with beta-caryophyllene and vaporized I did not notice it. I was really looking for any positive effects on the THC effects, there were none.
I do not like the smell or taste of beta-caryophyllene, it smells like hemp to me. I have smelled a lot of hemp in my life....
-SamS
it seems like a critical thinker might review the available evidence, explore these compounds themselves, analyze their current strains to become familiar with the most prominent compounds present, and not simply draw a line in the sand which seems tantamount to waiting for clinically available cannabis.
There's plenty of double blind studies. They're just not focusing on the psychoactive characteristics. It's not as if GW Pharma hasn't studied their area of expertise extensively. I wonder why there isn't more research into the psychoactive effects, I heard they're passing out licenses like candy. I also wonder how so many pharmaceutical companies can still be in business basing their businesses on such quasi scientific approaches.
The Wachtel study seems to fall short of anything remotely close to conclusive. It's not much of a placebo if you can identify a difference based on taste. Also the lack of less prominent cannabinoids, and unknown levels of terpenoids seem like a significant issue when attempting to identify ways in which they might modulate THC.
It's not difficult to order some essential oil and prove anecdotally to oneself that terpenes matter. Nobody said that beta-caryophyllene gets you high. It is a full CB2 agonist that has been shown to displace other cannabinoids. It's also been proven that CB1 and CB2 form functional heteromers and negatively modulate one another. Therefor it's not much of a leap of faith to assume that beta-caryophyllene present in high enough amounts modulates THC in at least those two ways. That's just one example. Are we better off remaining in the dark age until the gatekeepers provide clinically available cannabis?
Does it make sense to claim that all of the scientific evidence is worthless and that these compounds simply aren't relevant, even though there is absolutely no evidence to support that?